LEADER 04132nam 2201093z- 450 001 9910557598203321 005 20231214133339.0 035 $a(CKB)5400000000043695 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/76725 035 $a(EXLCZ)995400000000043695 100 $a20202201d2021 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aChagas Disease 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2021 215 $a1 electronic resource (150 p.) 311 $a3-0365-1248-9 311 $a3-0365-1249-7 330 $aDespite being described for the first time more than 110 years ago, Chagas disease (caused by the parasite Trypanosoma cruzi) persists as one of the most neglected tropical diseases. This persistent neglect of those affected by this disease is evidenced by the ongoing scientific evidence gaps, the difficulty of incorporating new diagnostic and treatment technologies into the market, and public health failures to ensure timely access to diagnosis and treatment associated with the development of consistent surveillance and control actions. As a result, there is a high burden of morbidity and mortality, and poor quality of life, poverty, stigma, and a fear of death persist for affected people, both in endemic areas in Latin America, and in non-endemic areas. This book spans a variety of disciplines and contributes significantly to reducing the gap in scientific knowledge on Chagas disease, towards achieving the Sustainable Development Goals by 2030. 606 $aMedicine$2bicssc 610 $aChagas disease 610 $aneglected tropical diseases 610 $amigration 610 $ahealthcare rights 610 $amucosal leishmaniasis 610 $aco-infection 610 $aantimoniate therapy 610 $acardiomyopathy 610 $amyocardial fibrosis 610 $amyocardial sympathetic denervation 610 $ainflammation 610 $asudden death 610 $acardiac magnetic resonance 610 $aradionuclide imaging 610 $aSPECT-CT 610 $aPET-CT 610 $aheart disease 610 $aelectrocardiogram 610 $adisease progression 610 $astroke 610 $arisk assessment 610 $aTrypanosoma cruzi 610 $aTriatoma infestans 610 $aparasite prevalence 610 $acoprophagy 610 $ahuman illness 610 $aneglected tropical disease 610 $aglobal financing 610 $aannual funding 610 $ainvestments 610 $adisease notification 610 $apublic policy 610 $aneglected topical diseases 610 $ahealthcare access 610 $achagasic cardiomyopathy 610 $aheart transplantation 610 $aChagas disease reactivation 610 $acardiac allograft rejection 610 $atreatment of reactivation 610 $agenome 610 $aparasite 610 $aneglected diseases 610 $aheart transplant 610 $achagas disease reactivation 610 $aCohort studies 610 $aNeglected diseases 610 $aDynamic programming 610 $acost of illness 610 $apremature 610 $aefficiency 610 $aorganizational 610 $alife expectancy 610 $aAmerican trypanosomiasis 610 $aTrypanosoma cruzi infection 610 $apublic health 610 $aepidemiology 610 $aprevention and control 610 $asurveillance 610 $aclinical research 610 $aOne Health 615 7$aMedicine 700 $aHeukelbach$b Jorg$4edt$01303476 702 $aRamos Jr$b Alberto Novaes$4edt 702 $ade Sousa$b Andrea Silvestre$4edt 702 $aHeukelbach$b Jorg$4oth 702 $aRamos Jr$b Alberto Novaes$4oth 702 $ade Sousa$b Andrea Silvestre$4oth 906 $aBOOK 912 $a9910557598203321 996 $aChagas Disease$93027093 997 $aUNINA